{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:52:47Z","timestamp":1791211967909,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00277-020-04205-0","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T04:24:45Z","timestamp":1598502285000},"page":"2483-2495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1466","authenticated-orcid":false,"given":"Samir K.","family":"Ballas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlton","family":"Dampier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"4205_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease. N Engl J Med 376:1561\u20131573","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"4205_CR2","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","volume":"38","author":"KL Hassell","year":"2010","unstructured":"Hassell KL (2010) Population estimates of sickle cell disease in the U.S. Am J Prev Med 38(Suppl):S512\u2013S521","journal-title":"Am J Prev Med"},{"key":"4205_CR3","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2020.010","volume":"12","author":"SK Ballas","year":"2020","unstructured":"Ballas SK (2020) The evolving pharmacotherapeutic landscape for the treatment of sickle cell disease. Mediterr J Hematol Infect Dis 12:e2020010","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4205_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12955-019-1225-7","volume":"17","author":"N Shah","year":"2019","unstructured":"Shah N, Bhor M, Xie L, Halloway R, Arcona S, Paulose J, Yuce H (2019) Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study. Health Qual Life Outcomes 17:155","journal-title":"Health Qual Life Outcomes"},{"key":"4205_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ajh.23683","volume":"89","author":"H Elmariah","year":"2014","unstructured":"Elmariah H, Garrett ME, De Castro LM et al (2014) Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol 89:530\u2013535","journal-title":"Am J Hematol"},{"key":"4205_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1182\/blood-2016-05-716910","volume":"128","author":"K Gardner","year":"2016","unstructured":"Gardner K, Douiri A, Drasar E, Allman M, Mwirigi A, Awogbade M, Thein SL (2016) Survival in adults with sickle cell disease in a high-income setting. Blood 128:1436\u20131438","journal-title":"Blood"},{"issue":"Suppl","key":"4205_CR7","doi-asserted-by":"publisher","first-page":"S536","DOI":"10.1016\/j.amepre.2010.01.001","volume":"38","author":"HR Yusuf","year":"2010","unstructured":"Yusuf HR, Atrash HK, Grosse SD, Parker CS, Grant AM (2010) Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007. Am J Prev Med 38(Suppl):S536\u2013S541","journal-title":"Am J Prev Med"},{"key":"4205_CR8","unstructured":"Bhor M, Lin X, Paulose J, Yuce H, Shah N (2018) Primary reasons for sickle-cell disease-related hospital and emergency room visits in the US Medicaid population. Presented at: 46th Annual National Convention of the sickle cell disease Association of America (SCDAA); October 10-13, 2018; Baltimore, MD. https:\/\/scdaa46.sched.com\/event\/GZo8\/rate-of-vaso-occlusive-crisis-episodes-among-sickle-cell-disease-patients-in-the-us-medicaid-population."},{"key":"4205_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079923","volume":"8","author":"DS Darbari","year":"2013","unstructured":"Darbari DS, Wang Z, Kwak M, Hildesheim M, Nichols J, Allen D, Seamon C, Peters-Lawrence M, Conrey A, Hall MK, Kato GJ, Taylor VI JG (2013) Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One 8:e79923","journal-title":"PLoS One"},{"key":"4205_CR10","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.2010.378","volume":"303","author":"DC Brousseau","year":"2010","unstructured":"Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA (2010) Acute care utilization and rehospitalizations for sickle cell disease. JAMA 303:1288\u20131294","journal-title":"JAMA"},{"key":"4205_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ajem.2012.11.005","volume":"31","author":"C Haywood Jr","year":"2013","unstructured":"Haywood C Jr, Tanabe P, Naik R, Beach MC, Lanzkron S (2013) The impact of race and disease on sickle cell patient wait times in the emergency department. Am J Emerg Med 31:651\u2013656","journal-title":"Am J Emerg Med"},{"key":"4205_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/03630269.2016.1232272","volume":"40","author":"D Pulte","year":"2016","unstructured":"Pulte D, Lovett PB, Axelrod D, Crawford A, McAna J, Powell R (2016) Comparison of emergency department wait times in adults with sickle cell disease versus other painful etiologies. Hemoglobin 40:330\u2013334","journal-title":"Hemoglobin"},{"key":"4205_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/TME.0000000000000036","volume":"36","author":"CE Freiermuth","year":"2014","unstructured":"Freiermuth CE, Haywood C Jr, Silva S, Cline DM, Kayle M, Sullivan D, Thornton V, Tanabe P (2014) Attitudes toward patients with sickle cell disease in a multicenter sample of emergency department providers. Adv Emerg Nurs J 36:335\u2013347","journal-title":"Adv Emerg Nurs J"},{"key":"4205_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0885-3924(97)00019-5","volume":"14","author":"BS Shapiro","year":"1997","unstructured":"Shapiro BS, Benjamin LJ, Payne R, Heidrich G (1997) Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manag 14:168\u2013174","journal-title":"J Pain Symptom Manag"},{"key":"4205_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.annemergmed.2013.02.004","volume":"62","author":"JA Glassberg","year":"2013","unstructured":"Glassberg JA, Tanabe P, Chow A et al (2013) Emergency provider analgesic practices and attitudes toward patients with sickle cell disease. Ann Emerg Med 62:293\u2013302.e10","journal-title":"Ann Emerg Med"},{"key":"4205_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ajh.21807","volume":"85","author":"S Lanzkron","year":"2010","unstructured":"Lanzkron S, Carroll CP, Haywood C Jr (2010) The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database. Am J Hematol 85:797\u2013799","journal-title":"Am J Hematol"},{"key":"4205_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jamainternmed.2014.245","volume":"174","author":"PS Hussey","year":"2014","unstructured":"Hussey PS, Schneider EC, Rudin RS, Fox DS, Lai J, Pollack CE (2014) Continuity and the costs of care for chronic disease. JAMA Intern Med 174:742\u2013748","journal-title":"JAMA Intern Med"},{"key":"4205_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1477-7525-3-50","volume":"3","author":"DK McClish","year":"2005","unstructured":"McClish DK, Penberthy LT, Bovbjerg VE et al (2005) Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes 3:50","journal-title":"Health Qual Life Outcomes"},{"key":"4205_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ajh.10305","volume":"72","author":"P Houston-Yu","year":"2003","unstructured":"Houston-Yu P, Rana SR, Beyer B, Castro O (2003) Frequent and prolonged hospitalizations: a risk factor for early mortality in sickle cell disease patients. Am J Hematol 72:201\u2013203","journal-title":"Am J Hematol"},{"key":"4205_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.annemergmed.2008.07.050","volume":"53","author":"IP Aisiku","year":"2009","unstructured":"Aisiku IP, Smith WR, McClish DK et al (2009) Comparisons of high versus low emergency department utilizers in sickle cell disease. Ann Emerg Med 53:587\u2013593","journal-title":"Ann Emerg Med"},{"key":"4205_CR21","doi-asserted-by":"publisher","first-page":"8296139","DOI":"10.1155\/2018\/8296139","volume":"2018","author":"SM Badawy","year":"2018","unstructured":"Badawy SM, Barrera L, Cai S, Thompson AA (2018) Association between participants' characteristics, patient-reported outcomes, and clinical outcomes in youth with sickle cell disease. Biomed Res Int 2018:8296139","journal-title":"Biomed Res Int"},{"key":"4205_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jemermed.2014.12.080","volume":"49","author":"MA Blinder","year":"2015","unstructured":"Blinder MA, Duh MS, Sasane M, Trahey A, Paley C, Vekeman F (2015) Age-related emergency department reliance in patients with sickle cell disease. J Emerg Med 49:513\u2013522.e1","journal-title":"J Emerg Med"},{"key":"4205_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jpepsy\/jsj002","volume":"31","author":"RT Brown","year":"2006","unstructured":"Brown RT, Connelly M, Rittle C, Clouse B (2006) A longitudinal examination predicting emergency room use in children with sickle cell disease and their caregivers. J Pediatr Psychol 31:163\u2013173","journal-title":"J Pediatr Psychol"},{"key":"4205_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/phn.12643","volume":"36","author":"EP Caldwell","year":"2019","unstructured":"Caldwell EP (2019) The influence of health literacy on emergency department utilization and hospitalizations in adolescents with sickle cell disease. Public Health Nurs 36:765\u2013771","journal-title":"Public Health Nurs"},{"key":"4205_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/AJP.0b013e3182579b87","volume":"29","author":"PC Carroll","year":"2013","unstructured":"Carroll PC, Haywood C Jr, Hoot MR, Lanzkron S (2013) A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients. Clin J Pain 29:317\u2013323","journal-title":"Clin J Pain"},{"key":"4205_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133116","volume":"10","author":"SA Curtis","year":"2015","unstructured":"Curtis SA, Danda N, Etzion Z, Cohen HW, Billett HH (2015) Elevated steady state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia. PLoS One 10:e0133116","journal-title":"PLoS One"},{"key":"4205_CR27","first-page":"1109","volume":"98","author":"K Epstein","year":"2006","unstructured":"Epstein K, Yuen E, Riggio JM, Ballas SK, Moleski SM (2006) Utilization of the office, hospital and emergency department for adult sickle cell patients: a five-year study. J Natl Med Assoc 98:1109\u20131113","journal-title":"J Natl Med Assoc"},{"key":"4205_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bjh.12049","volume":"159","author":"JA Glassberg","year":"2012","unstructured":"Glassberg JA, Chow A, Wisnivesky J, Hoffman R, Debaun MR, Richardson LD (2012) Wheezing and asthma are independent risk factors for increased sickle cell disease morbidity. Br J Haematol 159:472\u2013479","journal-title":"Br J Haematol"},{"key":"4205_CR29","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/j.annemergmed.2012.06.124","volume":"60","author":"JW Hafner","year":"2012","unstructured":"Hafner JW, Grinhaug E, Wang H, Tanabe P, Artz N, Martinovich Z (2012) Association of concurrent ICD-9 diagnoses in patients with sickle cell disease with emergency department visit frequency and disposition. Ann Emerg Med 60:S53\u2013S54","journal-title":"Ann Emerg Med"},{"key":"4205_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/ajh.22106","volume":"86","author":"BG Hemker","year":"2011","unstructured":"Hemker BG, Brousseau DC, Yan K, Hoffmann RG, Panepinto JA (2011) When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department. Am J Hematol 86:863\u2013865","journal-title":"Am J Hematol"},{"key":"4205_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12529-016-9538-y","volume":"23","author":"CR Jonassaint","year":"2016","unstructured":"Jonassaint CR, Beach MC, Haythornthwaite JA, Bediako SM, Diener-West M, Strouse JJ, Lanzkron S, Onojobi G, Carroll CP, Haywood C Jr (2016) The association between educational attainment and patterns of emergency department utilization among adults with sickle cell disease. Int J Behav Med 23:300\u2013309","journal-title":"Int J Behav Med"},{"key":"4205_CR32","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood.V116.21.1534.1534","volume":"116","author":"S Kamble","year":"2010","unstructured":"Kamble S, Reed SD, Flahiff C, Adam S, DeCastro LM (2010) Resource use and expenditures among adult sickle cell patients with and without depression. Blood 116:1534","journal-title":"Blood"},{"key":"4205_CR33","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/pbc.25141","volume":"61","author":"RD Latzman","year":"2014","unstructured":"Latzman RD, Shishido Y, Latzman NE, Elkin TD, Majumdar S (2014) Associations among emergency room visits, parenting styles, and psychopathology among pediatric patients with sickle cell. Pediatr Blood Cancer 61:1822\u20131827","journal-title":"Pediatr Blood Cancer"},{"key":"4205_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/jwh.2006.15.146","volume":"15","author":"DK McClish","year":"2006","unstructured":"McClish DK, Levenson JL, Penberthy LT et al (2006) Gender differences in pain and healthcare utilization for adult sickle cell patients: the PiSCES project. J Women's Health (Larchmt) 15:146\u2013154","journal-title":"J Women's Health (Larchmt)"},{"key":"4205_CR35","doi-asserted-by":"publisher","unstructured":"Morrison AK, Myrvik MP, Brousseau DC et al (2018) Parents\u2019 pain medication underdosing is associated with more emergency department visits in sickle cell disease. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26906","DOI":"10.1002\/pbc.26906"},{"key":"4205_CR36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/pbc.22069","volume":"53","author":"M Mvundura","year":"2009","unstructured":"Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD (2009) Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer 53:642\u2013646","journal-title":"Pediatr Blood Cancer"},{"key":"4205_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/02739615.2018.1454838","volume":"48","author":"A Pantaleao","year":"2019","unstructured":"Pantaleao A, DiPlacido J, Guite JW, Zempsky WT (2019) Caregiver factors related to emergency department utilization for youth with sickle cell disease. Child Health Care 48:59\u201374","journal-title":"Child Health Care"},{"key":"4205_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1359105309345554","volume":"15","author":"KA Sanders","year":"2010","unstructured":"Sanders KA, Labott SM, Molokie R, Shelby SR, Desimone J (2010) Pain, coping and health care utilization in younger and older adults with sickle cell disease. J Health Psychol 15:131\u2013137","journal-title":"J Health Psychol"},{"key":"4205_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pbc.21066","volume":"50","author":"SM Shankar","year":"2008","unstructured":"Shankar SM, Arbogast PG, Mitchel E, Ding H, Wang WC, Griffin MR (2008) Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease. Pediatr Blood Cancer 50:66\u201371","journal-title":"Pediatr Blood Cancer"},{"key":"4205_CR40","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1097\/MPH.0000000000001533","volume":"41","author":"A Singh","year":"2019","unstructured":"Singh A, Yan K, Brandow AM, Panepinto JA (2019) Longitudinal trend in emergency department reliance for pain among sickle cell disease patients in Wisconsin. J Pediatr Hematol Oncol 41:e438\u2013e442","journal-title":"J Pediatr Hematol Oncol"},{"key":"4205_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1524-9042(02)54211-9","volume":"4","author":"WR Smith","year":"2003","unstructured":"Smith WR, Coyne P, Smith VS, Mercier B (2003) Temperature changes, temperature extremes, and their relationship to emergency department visits and hospitalizations for sickle cell crisis. Pain Manag Nurs 4:106\u2013111","journal-title":"Pain Manag Nurs"},{"key":"4205_CR42","first-page":"1056","volume":"102","author":"MV Stanton","year":"2010","unstructured":"Stanton MV, Jonassaint CR, Bartholomew FB, Edwards C, Richman L, DeCastro L, Williams R (2010) The association of optimism and perceived discrimination with health care utilization in adults with sickle cell disease. J Natl Med Assoc 102:1056\u20131063","journal-title":"J Natl Med Assoc"},{"key":"4205_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13548506.2018.1516294","volume":"24","author":"AP Tackett","year":"2019","unstructured":"Tackett AP, Leavens ELS, Wiedenmann A, Perez MN, Baker A, Mayes S, Mullins LL, Wagener TL (2019) Preliminary exploration of secondhand smoke exposure in youth with sickle cell disease: biochemical verification, pulmonary functioning, and health care utilization. Psychol Health Med 24:35\u201342","journal-title":"Psychol Health Med"},{"key":"4205_CR44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3111\/13696998.2015.1117979","volume":"19","author":"F Vekeman","year":"2016","unstructured":"Vekeman F, Sasane M, Cheng WY, Ramanakumar AV, Fortier J, Qiu Y, Duh MS, Paley C, Adams-Graves P (2016) Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia. J Med Econ 19:292\u2013303","journal-title":"J Med Econ"},{"key":"4205_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pbc.22979","volume":"58","author":"JA Wolfson","year":"2012","unstructured":"Wolfson JA, Schrager SM, Khanna R, Coates TD, Kipke MD (2012) Sickle cell disease in California: sociodemographic predictors of emergency department utilization. Pediatr Blood Cancer 58:66\u201373","journal-title":"Pediatr Blood Cancer"},{"key":"4205_CR46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.pedn.2016.06.008","volume":"31","author":"M Kayle","year":"2016","unstructured":"Kayle M, Tanabe P, Shah NR, Baker-Ward L, Docherty SL (2016) Challenges in shifting management responsibility from parents to adolescents with sickle cell disease. J Pediatr Nurs 31:678\u2013690","journal-title":"J Pediatr Nurs"},{"key":"4205_CR47","doi-asserted-by":"publisher","first-page":"E345","DOI":"10.1002\/ajh.25233","volume":"93","author":"SK Ballas","year":"2018","unstructured":"Ballas SK, Kanter J, Agodoa I, Howard R, Wade S, Noxon V, Dampier C (2018) Opioid utilization patterns in United States individuals with sickle cell disease. Am J Hematol 93:E345\u2013E347","journal-title":"Am J Hematol"},{"key":"4205_CR48","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/ajh.25168","volume":"93","author":"CP Carroll","year":"2018","unstructured":"Carroll CP, Cichowitz C, Yu T, Olagbaju YO, Nelson JA, Campbell T, Lanzkron S (2018) Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: the role of non-hematologic characteristics and baseline chronic opioid dose. Am J Hematol 93:1127\u20131135","journal-title":"Am J Hematol"},{"key":"4205_CR49","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/bloodadvances.2018018382","volume":"2","author":"S Lanzkron","year":"2018","unstructured":"Lanzkron S, Little J, Field J, Shows JR, Wang H, Seufert R, Brooks J, Varadhan R, Haywood C Jr, Saheed M, Huang CY, Griffin B, Frymark S, Piehet A, Robertson D, Proudford M, Kincaid A, Green C, Burgess L, Wallace M, Segal J (2018) Increased acute care utilization in a prospective cohort of adults with sickle cell disease. Blood Adv 2:2412\u20132417","journal-title":"Blood Adv"},{"key":"4205_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jen.2017.04.009","volume":"43","author":"SK Smith","year":"2017","unstructured":"Smith SK, Johnston J, Rutherford C, Hollowell R, Tanabe P (2017) Identifying social-behavioral health needs of adults with sickle cell disease in the emergency department. J Emerg Nurs 43:444\u2013450","journal-title":"J Emerg Nurs"},{"key":"4205_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1542\/peds.2007-2875","volume":"123","author":"SD Grosse","year":"2009","unstructured":"Grosse SD, Schechter MS, Kulkarni R, Lloyd-Puryear MA, Strickland B, Trevathan E (2009) Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics 123:407\u2013412","journal-title":"Pediatrics"},{"key":"4205_CR52","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","volume":"95","author":"LJ Benjamin","year":"2000","unstructured":"Benjamin LJ, Swinson GI, Nagel RL (2000) Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood 95:1130\u20131136","journal-title":"Blood"},{"key":"4205_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5811\/westjem.2016.11.32273","volume":"18","author":"GG Simpson","year":"2017","unstructured":"Simpson GG, Hahn HR, Powel AA, Leverence RR, Morris LA, Thompson LG, Zumberg MS, Borde DJ, Tyndall JA, Shuster JJ, Yealy DM, Allen BR (2017) A patient-centered emergency department management strategy for sickle-cell disease super-utilizers. West J Emerg Med 18:335\u2013339","journal-title":"West J Emerg Med"},{"key":"4205_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1062860617707262","volume":"33","author":"RE Powell","year":"2018","unstructured":"Powell RE, Lovett PB, Crawford A, McAna J, Axelrod D, Ward L, Pulte D (2018) A multidisciplinary approach to impact acute care utilization in sickle cell disease. Am J Med Qual 33:127\u2013131","journal-title":"Am J Med Qual"},{"key":"4205_CR55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2218","volume":"143","author":"L Balsamo","year":"2019","unstructured":"Balsamo L, Shabanova V, Carbonella J, Szondy MV, Kalbfeld K, Thomas DA, Santucci K, Grossman M, Pashankar F (2019) Improving care for sickle cell pain crisis using a multidisciplinary approach. Pediatrics 143:e20182218","journal-title":"Pediatrics"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04205-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04205-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04205-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T21:06:06Z","timestamp":1650229566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04205-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04205-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Samir K. Ballas has served on the speakers\u2019 bureau for Novartis Pharmaceuticals Corporation and has received honoraria from Novartis Pharmaceuticals Corporation. Dr. Carlton Dampier has received research funding from the Katz Foundation, the National Institutes of Health-National Institute of Child Health and Human Development and National Center for Advancing Translational Sciences, Merck & Co., Micelle BioPharma, Inc., Novartis Pharmaceuticals Corporation, and Pfizer Inc. He has been a consultant for Epizyme, Inc., Global Blood Therapeutics, Inc., Hilton Publishing Company, Ironwood Pharmaceuticals, Inc., Micelle BioPharma, Inc., Modus Therapeutics AB, Novartis Pharmaceuticals Corporation, and Pfizer Inc. He has also served on advisory boards for Micelle BioPharma, Inc., Novartis Pharmaceuticals Corporation, and Pfizer Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by either author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}